PG

Phil Grayeski

Partner at KdT Ventures

Raleigh-Durham-Chapel Hill Area

Overview

Work Experience

  • Partner

    2021 - Current

    Board Observer: - Radar Therapeutics - Tacit Therapeutics - Circularis (acq. by Gingko Q4 2022) - Transcera

  • Principal

    2019 - 2021

  • Venture Associate

    2018 - 2019

  • Board Member

    2023

  • Board Member

    2022

  • Board Member

    2020

  • Co-Founder

    2018

  • Board Member

    2021 - 2023

  • Board Member

    2021 - 2023

  • Strategy Advisor and Business Analyst

    2015 - 2019

    Acq. by Gingko Bioworks - May 2023

  • Strategy Advisor and Business Analyst

    2016 - 2017

Relevant Websites